Evaluation reports
EN
GPMCND - Génomique et médecine personnalisée du cancer et des maladies neuropsychiatriques
Type: Research entity evaluation report
Evaluation campaign: 2020-2022 (group B)
- Published on: 23/09/2021
Institution(s) concerned:
Institut national de la santé et de la recherche médicale - INSERM
, Université de Rouen Normandie
Disciplinary research field: Life and Earth Sciences (SVE) ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS5 Neurosciences and neural disorders: neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, neuroimaging, systems neuroscience, neurological disorders, psychiatry ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics
Name of unit teams: Genetic predisposition to cancer ; Genomics and biomarkers of lymphoma and solid tumours ; Genomics for Brain Disorders ; Epigenetics and Pathophysiology of Neurodevelopmental Disorders ; Genetics, Biology and Plasticity of Brain Tumours